Jun-Hee Woo
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 4
-
- Antimicrobial Resistance in Staphylococcus 3
- HIV/AIDS drug development and treatment 1
- Co-authors
- Jiso Ryu (7 shared papers)Yang Soo Kim (8 shared papers)Nam Joong Kim (5 shared papers)Sang‐Ho Choi (5 shared papers)Jin-Won Chung (2 shared papers)Sang‐Oh Lee (3 shared papers)Tae Hyong Kim (1 shared paper)Baek-Nam Kim (3 shared papers)
- Journals
- Scandinavian Journal of Infectious Diseases (1 paper)International Journal of Antimicrobial Agents (1 paper)Chemotherapy (1 paper)Molecules and Cells (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- South Korea
In The Last Decade
Jun-Hee Woo
11 papers receiving 337 citations
Peers
Comparison fields: 5 of 50
- Molecular Medicine 170
- Applied Microbiology and Biotechnology 27
- Endocrinology 42
- Critical Care and Intensive Care Medicine 27
- Microbiology 4
Countries citing papers authored by Jun-Hee Woo
This map shows the geographic impact of Jun-Hee Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-Hee Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-Hee Woo more than expected).
Fields of papers citing papers by Jun-Hee Woo
This network shows the impact of papers produced by Jun-Hee Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-Hee Woo. The network helps show where Jun-Hee Woo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun-Hee Woo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 156 | |
| 2 | 2003 | 92 | |
| 3 | 2002 | 57 | |
| 4 | 1994 | 23 | |
| 5 | 2003 | 10 | |
| 6 | 2000 | 9 | |
| 7 | 2019 | 9 | |
| 8 | Clinical Efficacy and Safety with Arbekacin for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections | 2003 | 5 |
| 9 | 2012 | 4 | |
| 10 | 1995 | 3 | |
| 11 | 1997 | 3 | |
| 12 | 2002 | 1 | |
| 13 | 1995 | 0 | |
| 14 | In vitro antimicrobial activity of cefditoren against Streptococcus pneumoniae and Haemophilus influenzae clinical isolates | 2007 | 0 |
About Jun-Hee Woo
Jun-Hee Woo is a scholar working on Molecular Medicine, Infectious Diseases, Pharmacology, Epidemiology and Microbiology, having authored 14 papers that have together received 372 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Urinary Tract Infections Management (1 paper), Nosocomial Infections in ICU (1 paper), HIV/AIDS drug development and treatment (1 paper) and Infections and bacterial resistance (1 paper). The work is most often cited by research in Molecular Medicine (170 citations), Applied Microbiology and Biotechnology (27 citations), Endocrinology (42 citations), Critical Care and Intensive Care Medicine (27 citations) and Microbiology (4 citations). Jun-Hee Woo has collaborated with scholars based in South Korea. Frequent co-authors include Jiso Ryu, Yang Soo Kim, Nam Joong Kim, Sang‐Ho Choi, Jin-Won Chung, Sang‐Oh Lee, Tae Hyong Kim, Baek-Nam Kim, Mi‐Na Kim and In‐Gyu Bae. Their work appears in journals such as Scandinavian Journal of Infectious Diseases, International Journal of Antimicrobial Agents, Chemotherapy, Molecules and Cells and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.